The cannabis industry stands at a historic inflection point. With the December 18, 2025, Executive Order directing the Department of Justice to expedite the rescheduling of cannabis to Schedule III, operators are preparing for a seismic shift in federal tax liability and regulatory oversight. However, this federal momentum does not erase the intricate, highly localized compliance burdens that dictate day-to-day operations.
What Are You Looking to Do?
Whether you are a multi-state operator expanding into a new limited-license market or a startup cultivator drafting your first standard operating procedures, success requires deterministic execution. Select your primary objective below to access our specialized knowledge base.
Start a Business
Navigate entity selection, capitalization requirements, and the impending sunset of IRC Section 280E.
Secure a License
Master the state licensing gauntlet, from merit-based application scoring to mandatory background checks.
Maintain Compliance
Prepare for state regulatory audits, manage METRC track-and-trace inventory, and prevent license revocation.
Protect Your Assets
Secure intellectual property, negotiate commercial real estate leases, and structure compliant M&A transactions.
The Shifting Federal Landscape: Schedule III & Executive Orders
For decades, cannabis has been classified as a Schedule I controlled substance under the Controlled Substances Act (CSA), placing it in the same category as heroin and creating insurmountable barriers to standard business operations. The most punitive of these barriers is Internal Revenue Code (IRC) Section 280E, which prohibits businesses trafficking in Schedule I or II substances from deducting ordinary and necessary business expenses. Under 280E, cannabis operators can only deduct the Cost of Goods Sold (COGS), resulting in effective federal tax rates that frequently exceed 70 percent.
The regulatory environment shifted dramatically on December 18, 2025, when President Trump signed an Executive Order instructing the Attorney General and the Drug Enforcement Administration (DEA) to expedite the final rulemaking process to reclassify cannabis as a Schedule III substance. This directive builds upon the Department of Health and Human Services' (HHS) 2023 scientific recommendation and effectively bypasses the administrative delays that stalled the DEA's January 2025 hearings.
Moving cannabis to Schedule III fundamentally alters the financial viability of the industry. Because IRC 280E only applies to Schedule I and II substances, a finalized Schedule III designation removes this crushing tax burden. Cannabis dispensaries, cultivators, and processors will finally be permitted to claim standard business deductions under IRC Section 162, including payroll, commercial rent, marketing, and administrative overhead. However, Schedule III is not federal legalization. State-level regulatory frameworks, FDA oversight, and stringent Department of Transportation (DOT) drug testing mandates for safety-sensitive roles remain fully intact. Operators must proactively restructure their tax strategies and corporate entities now to capitalize on the impending rule change.
State-by-State Regulatory Guides
Federal rescheduling does not preempt state law. The cannabis industry remains a patchwork of highly localized, heavily regulated markets. Securing a state license is only half the battle; operators must also navigate the "dual-licensing hurdle," securing local municipal authorization - such as conditional use permits and CEQA compliance in California - before state regulators will issue an active license.
California
Navigate the Department of Cannabis Control (DCC) regulations, understand the state's complex licensing tiers, and master the METRC track-and-trace system.
Oregon
Explore the mature regulatory framework overseen by the Oregon Liquor and Cannabis Commission (OLCC), including specific rules for producers, processors, and retailers.
Washington
Review the legacy of Initiative 502 and the strict tied-house rules enforced by the Washington State Liquor and Cannabis Board (LCB).
Illinois
Strategize for success in a highly restricted, limited-license market governed by the Department of Financial and Professional Regulation (IDFPR) and the Department of Agriculture.
Essential Legal Frameworks
Beyond state licensing, cannabis businesses face unique legal hurdles that require specialized corporate structuring and risk mitigation strategies. Standard boilerplate contracts and traditional business practices frequently fail when applied to the cannabis sector due to the lingering threat of federal forfeiture and the lack of bankruptcy protection.
Regulatory Compliance & Audits
Non-compliance is the single greatest threat to a cannabis business. Our frameworks detail the exact infractions state inspectors target, from 90-day security camera retention failures to visitor log discrepancies.
Business Formations & Tax Strategy
Entity selection is critical. We analyze the structural advantages of LLCs versus C-Corps in the context of IRC 280E and the transition to Schedule III.
Real Estate & Zoning
Securing compliant real estate is a prerequisite for licensing. Our guides explain municipal zoning setbacks, the "Green Zone" premium, and how to draft commercial leases that protect both landlords and tenants.
Intellectual Property
The USPTO routinely rejects trademarks for federally illegal cannabis products. We outline alternative brand protection strategies, including state-level registrations and federal filings for hemp-derived products.